A series of 1-arylpyrrolo[1,2-a]pyrazine-3-carboxamides were designed and synthesized as 18kDa translocator protein (TSPO) ligands. Anxiolytic-like activity of compounds was evaluated in the open field test and elevated plus maze test. Compounds 1a and 1b demonstrated high anxiolytic-like effect in the dose range of 0.1-1.0mg/kg comparable with that of diazepam. The involvement of TSPO receptor in the mechanism of anxiolytic-like activity of new compounds was proved by antagonism of the most active compound 1a with TSPO selective inhibitor PK11195. In vitro binding studies demonstrated high TSPO affinities for compounds 1a and 1b.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.bmc.2015.04.049DOI Listing

Publication Analysis

Top Keywords

anxiolytic-like activity
12
activity compounds
8
demonstrated high
8
design synthesis
4
anxiolytic-like
4
synthesis anxiolytic-like
4
activity 1-arylpyrrolo[12-a]pyrazine-3-carboxamides
4
1-arylpyrrolo[12-a]pyrazine-3-carboxamides series
4
series 1-arylpyrrolo[12-a]pyrazine-3-carboxamides
4
1-arylpyrrolo[12-a]pyrazine-3-carboxamides designed
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!